ProclaRx LLC
PrivateLast Round
Early Funding
Aug 17, 2016
Total Funding Raised
$6.5M
Company Overview
ProclaRx LLC is a biotechnology company that develops anti-infective therapeutics and technologies designed to inhibit and prevent bacterial biofilms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProclaRx LLC Comparables
Compare ProclaRx LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTryp Therapeutics | 78% | |
| Microbion Corporation | 78% | |
| Peptilogics | 76% | |
ProclaRx LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 17, 2016 | ||||
| Grant | Apr 30, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2016
$6.4M raised in early funding.
- Apr 30, 2016
$100K grant received from Ohio Third Frontier.
ProclaRx LLC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ProclaRx LLC's valuation, stock price, and market status.